Andelé M. Conradie

487 total citations
20 papers, 352 citations indexed

About

Andelé M. Conradie is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Andelé M. Conradie has authored 20 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 5 papers in Infectious Diseases and 4 papers in Molecular Biology. Recurrent topics in Andelé M. Conradie's work include Herpesvirus Infections and Treatments (11 papers), Cytomegalovirus and herpesvirus research (11 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Andelé M. Conradie is often cited by papers focused on Herpesvirus Infections and Treatments (11 papers), Cytomegalovirus and herpesvirus research (11 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Andelé M. Conradie collaborates with scholars based in Germany, Egypt and United States. Andelé M. Conradie's co-authors include Luca D. Bertzbach, Benedikt B. Kaufer, Yu You, Jakob Trimpert, Mark S. Parcells, Dušan Kunec, Nikolaus Osterrieder, Markus Landthaler, Hongwei Zhang and Sebastian Rausch and has published in prestigious journals such as Journal of Virology, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Andelé M. Conradie

19 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andelé M. Conradie Germany 10 177 105 83 71 51 20 352
Fabien Dorange France 6 186 1.1× 57 0.5× 76 0.9× 43 0.6× 38 0.7× 7 312
Erik Dietzel Germany 13 259 1.5× 287 2.7× 105 1.3× 57 0.8× 57 1.1× 20 470
Jikai Zhang China 15 180 1.0× 201 1.9× 85 1.0× 54 0.8× 92 1.8× 32 432
Xiaobing Mo China 10 133 0.8× 91 0.9× 75 0.9× 96 1.4× 79 1.5× 19 350
Rolf Suter United States 7 93 0.5× 121 1.2× 188 2.3× 48 0.7× 110 2.2× 8 359
Sohui T. Won United States 6 132 0.7× 71 0.7× 98 1.2× 26 0.4× 73 1.4× 8 282
Jason P. Laliberte United States 7 178 1.0× 79 0.8× 98 1.2× 53 0.7× 66 1.3× 8 358
Aparna Talekar United States 9 310 1.8× 168 1.6× 90 1.1× 32 0.5× 60 1.2× 9 401
Emilio Ortiz-Riaño United States 11 184 1.0× 343 3.3× 132 1.6× 49 0.7× 114 2.2× 15 561
D. Hannaman United States 9 81 0.5× 133 1.3× 98 1.2× 31 0.4× 130 2.5× 10 342

Countries citing papers authored by Andelé M. Conradie

Since Specialization
Citations

This map shows the geographic impact of Andelé M. Conradie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andelé M. Conradie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andelé M. Conradie more than expected).

Fields of papers citing papers by Andelé M. Conradie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andelé M. Conradie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andelé M. Conradie. The network helps show where Andelé M. Conradie may publish in the future.

Co-authorship network of co-authors of Andelé M. Conradie

This figure shows the co-authorship network connecting the top 25 collaborators of Andelé M. Conradie. A scholar is included among the top collaborators of Andelé M. Conradie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andelé M. Conradie. Andelé M. Conradie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
You, Yu, et al.. (2024). Telomeric repeats in the commercial SB-1 vaccine facilitate viral integration and contribute to vaccine efficacy. npj Vaccines. 9(1). 154–154. 1 indexed citations
3.
Conradie, Andelé M., et al.. (2023). Viral and cellular telomerase RNAs possess host-specific anti-apoptotic functions. Microbiology Spectrum. 11(5). e0188723–e0188723. 3 indexed citations
4.
Bertzbach, Luca D., Clive A. Tregaskes, Rebecca J. Martin, et al.. (2022). The Diverse Major Histocompatibility Complex Haplotypes of a Common Commercial Chicken Line and Their Effect on Marek’s Disease Virus Pathogenesis and Tumorigenesis. Frontiers in Immunology. 13. 908305–908305. 7 indexed citations
5.
Lantier, Isabelle, Thibaut Larcher, Andelé M. Conradie, et al.. (2022). In vivo imaging reveals novel replication sites of a highly oncogenic avian herpesvirus in chickens. PLoS Pathogens. 18(8). e1010745–e1010745. 4 indexed citations
6.
Bertzbach, Luca D., Hicham Sid, Yu You, et al.. (2021). A Genetically Engineered Commercial Chicken Line Is Resistant to Highly Pathogenic Avian Leukosis Virus Subgroup J. Microorganisms. 9(5). 1066–1066. 16 indexed citations
7.
Seyler, Lisa, Christina Wangen, Luca D. Bertzbach, et al.. (2021). Combinatorial Drug Treatments Reveal Promising Anticytomegaloviral Profiles for Clinically Relevant Pharmaceutical Kinase Inhibitors (PKIs). International Journal of Molecular Sciences. 22(2). 575–575. 27 indexed citations
8.
Trimpert, Jakob, Kristina Dietert, Nadine Ebert, et al.. (2021). Development of Safe and Highly Protective Live-Attenuated SARS-CoV-2 Vaccine Candidates by Genome Recoding. SSRN Electronic Journal. 2 indexed citations
9.
Trimpert, Jakob, Kristina Dietert, Theresa C. Firsching, et al.. (2021). Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding. Cell Reports. 36(5). 109493–109493. 47 indexed citations
10.
You, Yu, et al.. (2021). The Marek's Disease Virus Unique Gene MDV082 Is Dispensable for Virus Replication but Contributes to a Rapid Disease Onset. Journal of Virology. 95(15). e0013121–e0013121. 2 indexed citations
11.
Trimpert, Jakob, Andelé M. Conradie, Emanuel Wyler, et al.. (2020). Mechanism of Virus Attenuation by Codon Pair Deoptimization. Cell Reports. 31(4). 107586–107586. 62 indexed citations
12.
Kooshkaki, Omid, Afshin Derakhshani, Andelé M. Conradie, et al.. (2020). Coronavirus Disease 2019: A Brief Review of the Clinical Manifestations and Pathogenesis to the Novel Management Approaches and Treatments. Frontiers in Oncology. 10. 572329–572329. 3 indexed citations
13.
Conradie, Andelé M., Luca D. Bertzbach, Jakob Trimpert, et al.. (2020). Distinct polymorphisms in a single herpesvirus gene are capable of enhancing virulence and mediating vaccinal resistance. PLoS Pathogens. 16(12). e1009104–e1009104. 32 indexed citations
14.
Conradie, Andelé M., et al.. (2020). Marek’s Disease Virus Requires Both Copies of the Inverted Repeat Regions for Efficient In Vivo Replication and Pathogenesis. Journal of Virology. 95(3). 16 indexed citations
15.
Bertzbach, Luca D., Andelé M. Conradie, Yu You, & Benedikt B. Kaufer. (2020). Latest Insights into Marek’s Disease Virus Pathogenesis and Tumorigenesis. Cancers. 12(3). 647–647. 61 indexed citations
16.
Bertzbach, Luca D., et al.. (2019). Artesunate derivative TF27 inhibits replication and pathogenesis of an oncogenic avian alphaherpesvirus. Antiviral Research. 171. 104606–104606. 12 indexed citations
17.
Conradie, Andelé M., et al.. (2019). A Common Live-Attenuated Avian Herpesvirus Vaccine Expresses a Very Potent Oncogene. mSphere. 4(5). 33 indexed citations
18.
Conradie, Andelé M., et al.. (2016). Establishment of different plasmid only-based reverse genetics systems for the recovery of African horse sickness virus. Virology. 499. 144–155. 14 indexed citations
19.
Conradie, Andelé M., et al.. (2016). African horse sickness virus infects BSR cells through macropinocytosis. Virology. 497. 217–232. 2 indexed citations
20.
Conradie, Andelé M., et al.. (2015). Directed genetic modification of African horse sickness virus by reverse genetics. South African Journal of Science. 111(7/8). 8–8. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabien Dorange Breakdown of academic impact, for papers by Erik Dietzel Breakdown of academic impact, for papers by Jikai Zhang Breakdown of academic impact, for papers by Xiaobing Mo Breakdown of academic impact, for papers by Rolf Suter Breakdown of academic impact, for papers by Sohui T. Won Breakdown of academic impact, for papers by Jason P. Laliberte Breakdown of academic impact, for papers by Aparna Talekar Breakdown of academic impact, for papers by Emilio Ortiz-Riaño Breakdown of academic impact, for papers by D. Hannaman
Rankless by CCL
2026